English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Gencurix Inc.
Press release submission
| Aug 12, 2019
GENCURIX INC.: New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger
Trending
Patient Daily
| Nov 5, 2025
Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+
Pharmaceuticals
Patient Daily
| Nov 6, 2025
Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
Patient Daily
| Nov 5, 2025
Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+
Pharmaceuticals
Patient Daily
| Nov 3, 2025
Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
